首页> 美国卫生研究院文献>Beilstein Journal of Nanotechnology >Identification of physicochemical properties that modulate nanoparticle aggregation in blood
【2h】

Identification of physicochemical properties that modulate nanoparticle aggregation in blood

机译:鉴定可调节血液中纳米颗粒聚集的理化特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inorganic materials are receiving significant interest in medicine given their usefulness for therapeutic applications such as targeted drug delivery, active pharmaceutical carriers and medical imaging. However, poor knowledge of the side effects related to their use is an obstacle to clinical translation. For the development of molecular drugs, the concept of safe-by-design has become an efficient pharmaceutical strategy with the aim of reducing costs, which can also accelerate the translation into the market. In the case of materials, the application these approaches is hampered by poor knowledge of how the physical and chemical properties of the material trigger the biological response. Hemocompatibility is a crucial aspect to take into consideration for those materials that are intended for medical applications. The formation of nanoparticle agglomerates can cause severe side effects that may induce occlusion of blood vessels and thrombotic events. Additionally, nanoparticles can interfere with the coagulation cascade causing both pro- and anti-coagulant properties. There is contrasting evidence on how the physicochemical properties of the material modulate these effects. In this work, we developed two sets of tailored carbon and silica nanoparticles with three different diameters in the 100–500 nm range with the purpose of investigating the role of surface curvature and chemistry on platelet aggregation, activation and adhesion. Substantial differences were found in the composition of the protein corona depending on the chemical nature of the nanoparticles, while the surface curvature was found to play a minor role. On the other hand, large carbon nanoparticles (but not small carbon nanoparticles or silica nanoparticles) have a clear tendency to form aggregates both in plasma and blood. This effect was observed both in the presence or absence of platelets and was independent of platelet activation. Overall, the results presented herein suggest the existence of independent modes of action that are differently affected by the physicochemical properties of the materials, potentially leading to vessel occlusion and/or formation of thrombi in vivo.
机译:鉴于无机材料可用于治疗应用,例如靶向药物输送,活性药物载体和医学成像,因此在医学界引起了极大兴趣。但是,对与使用它们相关的副作用的了解不足,这是临床翻译的障碍。对于分子药物的开发,“设计安全”的概念已成为一种有效的制药策略,旨在降低成本,这也可以加速向市场的转化。在材料的情况下,这些方法的应用由于对材料的物理和化学性质如何触发生物反应的了解不足而受到阻碍。血液相容性是考虑用于医疗用途的那些材料的关键方面。纳米颗粒附聚物的形成可引起严重的副作用,其可引起血管阻塞和血栓形成事件。另外,纳米粒子会干扰凝血级联反应,从而导致促凝和抗凝特性。关于材料的物理化学性质如何调节这些作用的证据相反。在这项工作中,我们研究了两组定制的碳纳米颗粒和二氧化硅纳米颗粒,它们在100-500 nm范围内具有三种不同的直径,目的是研究表面曲率和化学作用对血小板聚集,活化和粘附的作用。根据纳米粒子的化学性质,发现蛋白质电晕的组成存在很大差异,而表面曲率的作用较小。另一方面,大的碳纳米颗粒(而不是小的碳纳米颗粒或二氧化硅纳米颗粒)具有在血浆和血液中形成聚集体的明显趋势。在存在或不存在血小板的情况下均观察到该作用,并且与血小板活化无关。总体而言,本文呈现的结果表明存在独立的作用方式,该作用方式受到材料的物理化学性质的不同影响,可能在体内导致血管闭塞和/或血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号